EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ML281 Does Not Function as an STK33 Inhibitor but Modulates Proliferation and Differentiation of Keratinocytes Derived from Hypertrophic Scars

Ya Xin Zheng, Hui Song Cui, You Ra Lee, So Young Joo, Yoon Soo Cho iD, In Suk Kwak, Cheong Hoon Seo iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27188273 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Ya Xin Zheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Burn Institute, Department of Rehabilitation Medicine, College of Medicine, Hangang Sacred Heart Hospital, Hallym University, 94-200 Yeongdeungpo-Don…. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Keratinocytes, Cell Differentiation, Cicatrix, Hypertrophic. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Post-burn hypertrophic scar (HTS) formation is influenced by the dynamic balance between keratinocyte proliferation and differentiation, a process critical for maintaining skin homeostasis. Serine/threonine kinase 33 (STK33) has emerged as a potential therapeutic target in oncology. However, its role in HTS formation remains unclear, and its effects on keratinocytes are poorly understood. We isolated human HTS-derived keratinocytes (HTSKs) from post-burn HTS tissues and treated them with ML281, originally developed as an STK33 inhibitor. We examined markers associated with keratinocyte phenotypes and functions, including proliferation (proliferating cell nuclear antigen, c-Myc, keratins 5, 14, 6, 16, and 17), epithelial–mesenchymal transition (EMT; snail1, slug, twist1, e-cadherin, n-cadherin, and vimentin), differentiation (keratins 1 and 10, involucrin, loricrin, Notch1, p21, and p27), and apoptosis (cytochrome c, cleaved caspase3, Bid, Bad, Bax, and Bcl-2). mRNA and protein expression levels were assessed using reverse transcription–quantitative PCR, Western blotting, and immunocytochemistry. In HTSKs, ML281 increased STK33 enzymatic activity and STK33 mRNA and protein expression, rather than inhibiting STK33 activity. ML281 treatment reduced the expression of proliferation-associated markers, promoted an EMT-associated phenotype, modulated the expression of differentiation-associated markers, and induced apoptosis-associated changes. Collectively, these findings suggest that ML281 alters post-burn HTSK phenotypes associated with proliferation, EMT, differentiation, and apoptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Serine-Threonine KinasesKeratinocytesCell DifferentiationCicatrix, HypertrophicProtein Kinase InhibitorsHumansCell ProliferationEpithelial-Mesenchymal TransitionApoptosisCells, Cultured

Stichwörter der Autor:innen

ML281STK33keratinocytespost-burn hypertrophic scar

Substanzen

Protein Serine-Threonine KinasesProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Burn Institute, Department of Rehabilitation Medicine, College of Medicine, Hangang Sacred Heart Hospital, Hallym University, 94-200 Yeongdeungpo-Dong, Yeongdeungpo-Ku, Seoul 07247, Republic of Korea.
  • Department of Rehabilitation Medicine, College of Medicine, Hangang Sacred Heart Hospital, Hallym University, 94-200 Yeongdeungpo-Dong, Yeongdeungpo-Ku, Seoul 07247, Republic of Korea.
  • Department of Rehabilitation Medicine, National Fire Hospital, Chungbuk Innovation City 27740, Republic of Korea.
  • Seoul National University Hospital, Seoul 03080, Republic of Korea.
  • Department of Anesthesiology and Pain Medicine, Hangang Sacred Heart Hospital, College of Medicine, Hallym University, Seoul 07247, Republic of Korea.

ORCID-Profile: Yoon Soo Cho, Cheong Hoon Seo

Förderung

  • Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education
  • National Research Foundation of Korea

Zitieren

APA

Zheng, Y. X., Cui, H. S., Lee, Y. R., Joo, S. Y., Cho, Y. S., Kwak, I. S., & Seo, C. H. (2026). ML281 Does Not Function as an STK33 Inhibitor but Modulates Proliferation and Differentiation of Keratinocytes Derived from Hypertrophic Scars. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27188273

Vancouver

Zheng YX, Cui HS, Lee YR, Joo SY, Cho YS, Kwak IS, et al. ML281 Does Not Function as an STK33 Inhibitor but Modulates Proliferation and Differentiation of Keratinocytes Derived from Hypertrophic Scars. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27188273

BibTeX
@article{Zheng2026,
  author = {Zheng, Ya Xin and Cui, Hui Song and Lee, You Ra and Joo, So Young and Cho, Yoon Soo and Kwak, In Suk and Seo, Cheong Hoon},
  title = {ML281 Does Not Function as an STK33 Inhibitor but Modulates Proliferation and Differentiation of Keratinocytes Derived from Hypertrophic Scars},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27188273}
}
Kostenlos starten →